Fundamental Analysis of MEDIFAST INC - Growth / Value Index
MED - Valuation Highlights
Valuation Analysis
Tsr Value Index - Good Score of 78.12
Price to Earning Ratio is 4.03 and EV to EBITDA is 2.01 suggesting company is undervalued.
Book Value in last 3 years is trending up
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 4.15 | 2.34 | 15.97 % | |
| Price to Book | 1.46 | 1.40 | -25.47 % | 1.34 |
| Price to Sales | 0.313 | 0.231 | 27.08 % | |
| Enterprise Value to EBITDA Multiple | 2.10 | 1.18 | 10.17 % |
MED - Profitability Highlights
Profitability Analysis
Piotroski F Score - Good Value of 7.0
Gives Dividend Yield of 26.03 %
Earning Yield of 24.80 %
Over the last 3 years, the company has achieved Incredible Return on Equity
Over the last 3 years, the company has achieved Incredible Return on Assets
Strong Return On Capital Employed of 59.51
Company Earning excess return
During the past twelve months, the company has given a strong Return On Equity of 35.22%
During the past twelve months, the company has given a strong Return On Asset of 21.54%
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 35.22 | 59.51 | -35.73 % | 3.94 |
| Return On Asset | 21.54 | 38.69 | -14.79 % | 2.75 |
| Net Profit Margin | 7.55 | 9.84 | 9.58 % | 4.76 |
| Operating Profit Margin | 9.00 | 12.34 | 6.73 % | 4.54 |
| EBITDA Margin | 10.24 | 13.38 | 10.08 % | 7.04 |
Highlights
| Market Cap | 281523 K |
| Enterprise Value | 192968 K |
| Price/Book TTM | 1.46 |
| Outstanding Share | 10937.20 K |
| Float/ Outstanding Share | 88.50% |
| Dividend Yield | 25.29 % |
Share Holding
Guru Numbers
| Price/Graham No | 0.507 |
| Peter Lynch Ratio | -3.26 |
| Piotroski F Score | 7.00 |
| Altman Z Score | 8.38 |
| Sloan Ratio | -0.223 |
| Peter Lynch Fair Value | 101.70 |
MED - Growth Highlights
Growth Analysis
Tsr Growth Index - Good Score of 67.27
Quarterly sales in last 5 Quarter is trending down
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 897811 K | 23.79 % | 8.52 % |
| Gross Profit | 656753 K | 23.88 % | 9.96 % |
| EBITDA | 91921.00 K | 16.11 % | 2.33 % |
| Net Profit | 67762.00 K | 16.49 % | 37.80 % |
| EPS | 6.20 | 13.77 % | NA |
MED - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 89.29
Altman Z Score of 8.34 suggests good Stability
Interest Coverage of 0
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.0292 | -21.60 % | 0.0282 |
| Cash Ratio | 1.63 | 161.18 % | |
| Quick Ratio | 1.84 | 148.87 % | 2.25 |
| Shareholders Equity | 65.01 | 32.59 % | |
| Debt to EBITDA | 0.0361 | 21.45 % |
Historical Valuation Ratios of MEDIFAST INC
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of MEDIFAST INC
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of MEDIFAST INC
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of MEDIFAST INC
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)